Industries
Showing 271–280 of 281 results
-
Global Parenteral Nutrition Market 2022
Parenteral nutrition is the feeding of nutritional products to a person intravenously, bypassing the usual process of eating and digestion. The products provide liquid nutrients, including carbohydrates, proteins, fats, vitamins, minerals and electrolytes. Some people use parenteral nutrition to supplement feeding through a tube placed into the stomach or small bowel (enteral nutrition), and others use it by itself. The global parenteral nutrition market is poised to grow by US$ 1,564.4 million from 2022 to 2028, registering a CAGR of 4.1% during the forecast period, according to StrategyHelix. The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the parenteral nutrition market to help drive informed decision making for industry executives, policy makers, academic, and analysts.
-
Global Stem Cell Treatments for Cancer Market 2022
Cancer stem cells (CSCs) are responsible for carcinogenesis and tumorigenesis and are involved in drug and radiation resistance, metastasis, tumor relapse and initiation. According to a report by StrategyHelix, the global stem cell treatments for cancer market is set to increase by US$ 2,209.6 million during 2022-2028, growing at a CAGR of 11.8% during the forecast period. The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the stem cell treatments for cancer market to help drive informed decision making for industry executives, policy makers, academic, and analysts.
-
Global Nuclear Medicine & Radiopharmaceuticals Market 2022
Nuclear medicine is a medical specialty which uses radioactive tracers to diagnose and treat disease. Specially designed cameras allow doctors to track the circulation, uptake and excretion of these radioactive tracers. The global nuclear medicine & radiopharmaceuticals market is poised to grow by US$ 8,003.7 million during 2022-2028, progressing at a CAGR of 10.4% during the forecast period, according to data and analytics company StrategyHelix. The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the nuclear medicine & radiopharmaceuticals market to help drive informed decision making for industry executives, policy makers, academic, and analysts.
-
Global Oncology Based In-Vivo CRO Market 2022
In-vivo CRO refers to the preclinical testing performed for preclinical testing of disease pathology and drug discovery. It provides information regarding the collection and investigation of data for the development of new drugs for the treatment of various indications. According to a report by StrategyHelix, the global oncology based in-vivo cro market is set to increase by US$ 556.7 million during 2022-2028, growing at a CAGR of 6.8% during the forecast period. The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the oncology based in-vivo cro market to help drive informed decision making for industry executives, policy makers, academic, and analysts.
-
Global Radiotherapy, Nuclear Medicine & Radiopharmaceuticals Market 2022
Radiation therapy is the treatment of cancer and other diseases with radiation. Radiation in various forms is used to kill the cancer cells by preventing them from multiplying. Therapeutic radiology may be used to cure or control cancer, or to alleviate some of the symptoms associated with cancer. According to a report by StrategyHelix, the global radiotherapy, nuclear medicine & radiopharmaceuticals market is set to increase by US$ 12,637.9 million during 2022-2028, growing at a CAGR of 9.4% during the forecast period. The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the radiotherapy, nuclear medicine & radiopharmaceuticals market to help drive informed decision making for industry executives, policy makers, academic, and analysts.
-
Global Neurothrombectomy Devices Market 2022
A neurothrombectomy device is a device intended to retrieve or destroy blood clots in the cerebral neurovasculature by mechanical, laser, ultrasound technologies, or combination of technologies. The global neurothrombectomy devices market is set to increase by US$ 265.7 million from 2022 to 2028, representing a compound annual growth rate (CAGR) of 5.9% during the forecast period. The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the neurothrombectomy devices market to help drive informed decision making for industry executives, policy makers, academic, and analysts.
-
Global Smart Inhalers Market 2022
Inhalers are used to treat chronic obstructive pulmonary disease (COPD), such as asthma, by delivering bronchodilator medication to the airway directly, without passing through the blood. A smart inhaler is an inhaler that integrates connectivity with a mobile app, via Bluetooth, for instance. These devices are built with sensor technology that helps record data about the time and date of use, and the location of the patient at each use. According to StrategyHelix, the global smart inhalers market is expected to increase by US$ 536.4 million during 2022-2028, expanding at a CAGR of 21.7% during the forecast period. The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the smart inhalers market to help drive informed decision making for industry executives, policy makers, academic, and analysts.
-
Global Smart Biopsy Devices Market 2022
A biopsy is a diagnostic procedure where a tissue or cell sample is removed and then examined under a microscope. Biopsies are commonly used to determine whether a tumor or growth is cancerous or non-cancerous (benign). Smart biopsies allow real-time cancer tissue characterization and have been developed and are already being used in some hospitals to accelerate cancer diagnosis. The global smart biopsy devices market is poised to grow by US$ 792.8 million from 2022 to 2028, registering a CAGR of 4.3% during the forecast period, according to StrategyHelix. The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the smart biopsy devices market to help drive informed decision making for industry executives, policy makers, academic, and analysts.
-
Global Protein Assays Market 2022
The purpose of the protein assay is to determine the amount or concentration of a specific protein or an array of different proteins in a sample. Isolating and detecting protein is used for many clinical and research processes. This can be a primary step before further manipulation in a research and development process, an initial capture of protein before structural analysis, or it can be a final detection step in a clinical laboratory as part of a disease diagnosis. According to a report by StrategyHelix, the global protein assays market is set to increase by US$ 1,158.5 million during 2022-2028, growing at a CAGR of 9.2% during the forecast period. The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the protein assays market to help drive informed decision making for industry executives, policy makers, academic, and analysts.
-
Global Plasma Fractionation Market 2022
Plasma fractionation is the downstream processing of plasma that has been harvested by donors. It breaks plasma into individual proteins, or plasma fractions. A study by StrategyHelix indicates that the global plasma fractionation market is expected to increase by US$ 13.7 billion from 2022 to 2028, garnering a CAGR of 6.4% during the forecast period. The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the plasma fractionation market to help drive informed decision making for industry executives, policy makers, academic, and analysts.